Absence of mitogen-activated protein kinase family member c-Jun N-terminal kinase-2 enhances resistance to Toxoplasma gondii.

Experimental Parasitology
Woraporn SukhumavasiEric Y Denkers

Abstract

The function of mitogen-activated protein kinase (MAPK) family member c-Jun N-terminal kinase (JNK)-2 in resistance and pathology during infection has not been greatly studied. Here, we employed Jnk2(-/-) mice to investigate the role of JNK2 in resistance and immunity during oral infection with the protozoan pathogen Toxoplasma gondii. We found increased host resistance in the absence of JNK2 as determined by lower parasite burden and increased host survival. Lack of JNK2 also correlated with decreased neutrophil recruitment to the intestinal mucosa and less pathology in the small intestine. In the absence of JNK2, IL-12 production was slightly but significantly increased in restimulated splenocyte populations as well as in purified splenic dendritic cell cultures. These results provide evidence that expression of JNK2 plays a role in T. gondii-induced immunopathology, at the same time in promoting susceptibility to this parasitic pathogen.

References

Aug 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B J Luft, J S Remington
Feb 28, 2002·Annual Review of Immunology·Chen DongRichard A Flavell
Apr 3, 2002·The Journal of Experimental Medicine·Nathalie ArbourMichael B A Oldstone
Apr 3, 2002·The Journal of Experimental Medicine·Dietrich ConzeMercedes Rincón
Dec 3, 2003·American Journal of Respiratory and Critical Care Medicine·Li-Fu LiDeborah A Quinn
Mar 1, 2005·American Journal of Respiratory and Critical Care Medicine·Patrick G ArndtG Scott Worthen
Apr 30, 2005·Science·Felix YarovinskyAlan Sher
Sep 27, 2005·Clinical & Experimental Ophthalmology·Leila I KumpC S Foster
Feb 16, 2007·European Journal of Immunology·Jian TaoZhinan Yin
Feb 17, 2007·Current Opinion in Cell Biology·Claire R Weston, Roger J Davis

❮ Previous
Next ❯

Citations

Sep 14, 2011·Infection and Immunity·Pedro MorgadoMelissa B Lodoen
Sep 3, 2013·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Zhang YapingYao Xixian
Sep 8, 2010·Experimental Parasitology·Bernd H KalinnaAbhay R Satoskar
Nov 24, 2018·European Journal of Immunology·Jianyun LiuRandy R Brutkiewicz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.